Background*

Dr. Kleanthis G. Xanthopoulos, Ph.D. has been the Chief Executive Officer and President of Regulus Therapeutics Inc., since January 2009 and also has been its Principal Financial & Accounting Officer since June 21, 2013. Dr. Xanthopoulos serves as the Managing Director of Life Science Investments at Novera Optics, Inc. He serves as Senior Vice President at Isis Pharmaceuticals, Inc. He serves as a Member of the Executive Board at BIOCOM, Inc. He founded Sente, Inc. and ... served as its Chief Executive Officer and President. He served as the President and Chief Executive Officer at Regulus Therapeutics, LLC since joining in December 2007. He joined Regulus in 2007. He served as a Managing Director at Enterprise Partners Venture Capital since June 2006. Dr. Xanthopoulos co-founded Anadys Pharmaceuticals Inc. in May 2000 and served as its President and Chief Executive Officer until November 2006. He served as a Vice President at Isis Pharmaceuticals, Inc. From 1997 to 2000, he served as Vice President of Genomics & Molecular Biology of Aurora Biosciences Corporation from 1997 to 2000. He participated in The National Institutes of Health Human Genome Project and served as a Section Head of the National Human Genome Research Institute from 1995 to 1997. Dr. Xanthopoulos has been the Chairman of the Board of Apricus Biosciences, Inc. since December 2013 and its Director since November 17, 2011. He has been a Director of Regulus Therapeutics, LLC since January 2009 and Zosano Pharma Corporation since April 2013. He serves as an Executive Director of Regulus Therapeutics LLC. He serves as a Director of ZP Holdings Inc, Biocom SA, Southern California's Life Science Industry Association, Sente, Inc., Biotechnology Industry Organization (BIO) and Sente, Inc. He served as a Director of Anadys Pharmaceuticals Inc. from May 2000 to November 2011 and Zosano, Inc. from October 31, 2013 to April 7, 2014. He served as a Director of Odyssey Thera, Inc. He served as Associate Professor of Molecular Biology at the Karolinska Nobel Medical Institute, Stockholm, Sweden from 1991 to 1995, and Postdoctoral Research Fellow at The Rockefeller University from 1987 to 1990. An Onassis scholar, Dr. Xanthopoulos received B.Sc. in Biology with honors from Aristotle University of Thessaloniki, Greece, and received both his M.Sc. in Microbiology and Ph.D. in Molecular Biology from the University of Stockholm, Sweden.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.